Clinical Trial

Determining Patterns In Study Experiences of Neuroblastoma Patients

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Historically, participation in clinical research is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma. The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05918432
Lead Sponsor Power Life Sciences Inc.
Conditions Neuroblastoma
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-06-26